A study of renal cell carcinoma found that ZSCAN18 knockdown promoted proliferation of human embryonic kidney cells and the demethylation drug azacitidine (Aza) reversed upregulation of ZSCAN18 protein expression in various renal cell carcinoma cell lines (9). This evidence concerns the gene ZSCAN18 and renal cell carcinoma.